An outcome model approach to transporting a randomized controlled trial results to a target population.
Journal:
Journal of the American Medical Informatics Association : JAMIA
Published Date:
May 1, 2019
Abstract
OBJECTIVE: Participants enrolled into randomized controlled trials (RCTs) often do not reflect real-world populations. Previous research in how best to transport RCT results to target populations has focused on weighting RCT data to look like the target data. Simulation work, however, has suggested that an outcome model approach may be preferable. Here, we describe such an approach using source data from the 2 × 2 factorial NAVIGATOR (Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research) trial, which evaluated the impact of valsartan and nateglinide on cardiovascular outcomes and new-onset diabetes in a prediabetic population.
Authors
Keywords
Antihypertensive Agents
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Disease Progression
Electronic Health Records
Evidence-Based Medicine
Humans
Hypoglycemic Agents
Machine Learning
Nateglinide
Outcome Assessment, Health Care
Prediabetic State
Randomized Controlled Trials as Topic
Translational Research, Biomedical
Valsartan